• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中与血浆神经丝轻链升高相关的冷漠和情感症状,但与p-tau181无关。

Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease.

作者信息

Kang Matthew J Y, Eratne Dhamidhu, Loi Samantha M, Dang Christa, Santillo Alexander F, Zetterberg Henrik, Blennow Kaj, Mitchell Philip B, Hopwood Malcolm, Malpas Charles B, Velakoulis Dennis

机构信息

Neuropsychiatry Centre The Royal Melbourne Hospital Melbourne Victoria Australia.

Department of Psychiatry The University of Melbourne Melbourne Victoria Australia.

出版信息

Alzheimers Dement (Amst). 2025 Jul 29;17(3):e70151. doi: 10.1002/dad2.70151. eCollection 2025 Jul-Sep.

DOI:10.1002/dad2.70151
PMID:40735049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12305118/
Abstract

INTRODUCTION

Apathy and affective neuropsychiatric symptoms (NPS) are prevalent in Alzheimer's disease (AD), yet their neurobiological cause is still unclear. We examined associations between plasma neurofilament light chain (NfL) and tau pathology (p-tau181) with apathy and affective symptoms in mild cognitive impairment (MCI) and AD dementia.

METHODS

This longitudinal study analyzed data from 781 participants with MCI and AD dementia enrolled in ADNI, with annual blood samples collected over 4 years. NPS were assessed via the Neuropsychiatric Interview (NPI), and biomarker trajectories were analyzed using mixed-effects models.

RESULTS

Elevated plasma NfL levels were associated with apathy, anxiety and depression in MCI and AD dementia, with apathy linked to a significantly higher rate of NfL increase, indicating accelerated neurodegeneration.

DISCUSSION

Apathy and affective symptoms may indicate greater neurodegenerative burden in AD independent of tau-related pathology. Apathy was associated with a steeper rise in plasma NfL, suggesting a more aggressive disease progression.

HIGHLIGHTS

Apathy and affective neuropsychiatric symptoms (NPS) are highly prevalent in clinical Alzheimer's disease (AD).The presence of apathy, depression or anxiety was associated with higher plasma levels of neurofilament light chain (NfL).Apathy was associated with an accelerated increase in plasma NfL levels over time.Apathy and affective NPS were not associated with p-tau181 levels in plasma.

摘要

引言

冷漠和情感性神经精神症状(NPS)在阿尔茨海默病(AD)中很常见,但其神经生物学原因仍不清楚。我们研究了血浆神经丝轻链(NfL)和tau病理(p-tau181)与轻度认知障碍(MCI)和AD痴呆中的冷漠及情感症状之间的关联。

方法

这项纵向研究分析了参与阿尔茨海默病神经成像计划(ADNI)的781名MCI和AD痴呆患者的数据,在4年中每年采集血样。通过神经精神访谈(NPI)评估NPS,并使用混合效应模型分析生物标志物轨迹。

结果

血浆NfL水平升高与MCI和AD痴呆中的冷漠、焦虑和抑郁相关,冷漠与NfL升高的显著更高比率相关,表明神经退行性变加速。

讨论

冷漠和情感症状可能表明AD中更大的神经退行性负担,独立于tau相关病理。冷漠与血浆NfL的更陡峭上升相关,表明疾病进展更具侵袭性。

要点

冷漠和情感性神经精神症状(NPS)在临床阿尔茨海默病(AD)中高度普遍。冷漠、抑郁或焦虑的存在与血浆神经丝轻链(NfL)水平升高相关。随着时间推移冷漠与血浆NfL水平加速升高相关。冷漠和情感性NPS与血浆p-tau181水平无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6251/12305118/0661fb2d6b92/DAD2-17-e70151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6251/12305118/07f77593067c/DAD2-17-e70151-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6251/12305118/492638fdf869/DAD2-17-e70151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6251/12305118/0661fb2d6b92/DAD2-17-e70151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6251/12305118/07f77593067c/DAD2-17-e70151-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6251/12305118/492638fdf869/DAD2-17-e70151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6251/12305118/0661fb2d6b92/DAD2-17-e70151-g002.jpg

相似文献

1
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease.阿尔茨海默病中与血浆神经丝轻链升高相关的冷漠和情感症状,但与p-tau181无关。
Alzheimers Dement (Amst). 2025 Jul 29;17(3):e70151. doi: 10.1002/dad2.70151. eCollection 2025 Jul-Sep.
2
Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers.阿尔茨海默病中的精神病和与疾病相关的生物标志物升高。
JAMA Psychiatry. 2024 Aug 1;81(8):834-839. doi: 10.1001/jamapsychiatry.2024.1389.
3
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.
4
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study.血浆Aβ42/40比值、磷酸化tau181、胶质纤维酸性蛋白(GFAP)和神经丝轻链(NfL)在阿尔茨海默病和非阿尔茨海默病性痴呆连续病程中的诊断性能:一项国际多中心研究
Alzheimers Dement. 2025 Jun;21(6):e14573. doi: 10.1002/alz.14573.
5
Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.情感和植物神经领域的神经精神症状与轻度认知障碍和阿尔茨海默病老年人脑形态的相关性。
Int J Geriatr Psychiatry. 2023 Jun;38(6):e5952. doi: 10.1002/gps.5952.
6
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
7
Timing of changes in Alzheimer's disease plasma biomarkers as assessed by amyloid and tau PET clocks.通过淀粉样蛋白和tau PET时钟评估阿尔茨海默病血浆生物标志物变化的时间。
medRxiv. 2024 Nov 14:2024.10.25.24316144. doi: 10.1101/2024.10.25.24316144.
8
The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementia.血液生物标志物在帕金森病、阿尔茨海默病和额颞叶痴呆中的作用。
J Neurol Sci. 2025 Sep 15;476:123617. doi: 10.1016/j.jns.2025.123617. Epub 2025 Jul 11.
9
Sex differences in the relationships between 24-h rest-activity patterns and plasma markers of Alzheimer's disease pathology.24小时休息-活动模式与阿尔茨海默病病理血浆标志物之间关系的性别差异。
Alzheimers Res Ther. 2024 Dec 30;16(1):277. doi: 10.1186/s13195-024-01653-y.
10
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.

本文引用的文献

1
Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers.轻度行为障碍-淡漠与阿尔茨海默病核心脑脊液生物标志物
Brain. 2025 Jun 2. doi: 10.1093/brain/awaf194.
2
Machine learning reveals connections between preclinical type 2 diabetes subtypes and brain health.机器学习揭示了临床前2型糖尿病亚型与大脑健康之间的联系。
Brain. 2025 Apr 3;148(4):1389-1404. doi: 10.1093/brain/awaf057.
3
Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysis.
情绪和焦虑障碍中的神经丝轻链蛋白和胶质纤维酸性蛋白:一项系统评价和荟萃分析。
Brain Behav Immun. 2025 Jan;123:1091-1102. doi: 10.1016/j.bbi.2024.11.001. Epub 2024 Nov 5.
4
Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting.在临床环境中,血浆和脑脊液神经丝轻链可将神经退行性疾病与原发性精神疾病区分开来。
Alzheimers Dement. 2024 Nov;20(11):7989-8001. doi: 10.1002/alz.14278. Epub 2024 Oct 6.
5
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission.《痴呆症的预防、干预与照护:柳叶刀常设委员会2024年报告》
Lancet. 2024 Aug 10;404(10452):572-628. doi: 10.1016/S0140-6736(24)01296-0. Epub 2024 Jul 31.
6
Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers.阿尔茨海默病中的精神病和与疾病相关的生物标志物升高。
JAMA Psychiatry. 2024 Aug 1;81(8):834-839. doi: 10.1001/jamapsychiatry.2024.1389.
7
Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease.阿尔茨海默病中血浆生物标志物与数字认知测试的关系。
Alzheimers Dement (Amst). 2024 Apr 14;16(2):e12590. doi: 10.1002/dad2.12590. eCollection 2024 Apr-Jun.
8
Persistence of neuropsychiatric symptoms and dementia prognostication: A comparison of three operational case definitions of mild behavioral impairment.神经精神症状的持续存在与痴呆预后:三种轻度行为损害操作性病例定义的比较
Alzheimers Dement (Amst). 2023 Sep 30;15(4):e12483. doi: 10.1002/dad2.12483. eCollection 2023 Oct-Dec.
9
Associations between Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers in People with Mild Cognitive Impairment.轻度认知障碍患者的神经精神症状与阿尔茨海默病生物标志物之间的关联。
Brain Sci. 2023 Aug 12;13(8):1195. doi: 10.3390/brainsci13081195.
10
An Update on Apathy in Alzheimer's Disease.阿尔茨海默病中淡漠症状的最新进展
Geriatrics (Basel). 2023 Jul 14;8(4):75. doi: 10.3390/geriatrics8040075.